In Maryland, scientists have long known that breast cancer stem cells can survive chemotherapy, which is not good as those cells are usually in tumor centers and the ones you really want to get rid of because if they come back, the cancer is often fatal. Scientists found that proteins known as hypoxia-inducible factors (HIFs) are activated when exposed to chemotherapy and they then produce a protein called glutathione-S-transferase O1 (GSTO1) which turns on certain genes that help those nasty breast cancer stem cells survive. The gene expression analysis and experiments conducted in their lab showed that if they can block the HIFs, then the GSTO1 protein is never formed and the breast cancer stem cells couldn’t protect themselves against the chemotherapy, giving much hope for breast cancer patients.
Latest article
Cow cells to couture: Qorium raises $25M for cultivated leather
In the Netherlands, lab-grown leather startup Qorium has raised $25 million to increase its production capabilities and continue to establish commercial partnerships in high-end...
Acclaimed restaurant Noma partners with Novonesis to “take deliciousness to the next level”
In Denmark, Michelin star-mainstay Noma has partnered with biosolutions leader Novonesis to determine the potential of new biobased food ingredients within the Noma Projects...
KAIST team demonstrates use of bacteria to produce and dye cellulose
In South Korea, researchers have coaxed living bacteria to grow, weave, and dye fabrics without the use of oil, plastic or artificial dyes.
The...